Interesting data from Denmark*
From mid November to mid February, experienced a huge surge then huge fall in #SARSCoV2 cases
Over same period, more comtagiois #B117 grew from <0.1% of genotyped cases to about 50%
From mid November to mid February, experienced a huge surge then huge fall in #SARSCoV2 cases
Over same period, more comtagiois #B117 grew from <0.1% of genotyped cases to about 50%
https://twitter.com/kakape/status/1364527865639936002
I’m not sure what this means. Absolute numbers were decreasing, but country has been in a lockdown. They plan to start easing the lockdown slowly at end of Feb thelocal.dk/20210222/denma…
Also are in early stages of vaccination (like US) but moving deliberately to offer to whole population by mid-summer
Denmark is in early stages of vaccination (like US) but moving deliberately to offer to whole population by mid-summer
...and they ordered more Moderna/Pfizer than other countries that pinned hopes on AstraZeneca) irishtimes.com/news/world/eur…
...and they ordered more Moderna/Pfizer than other countries that pinned hopes on AstraZeneca) irishtimes.com/news/world/eur…
It’ll be instructive to see how the outbreak behaves in Denmark as they emerge from lockdown, with #B117 the majority of #SARSCoV2 variants but also increasing proportion of population vaccinated (they have more Moderna/Pfizer than several other EU countries)
For more info, here’s a great story by @kakape from a couple weeks ago laying out the situation and considerations at play:
https://twitter.com/kakape/status/1364530235597869060
* Some of my interpretation depends on my Google-aided translation of Danish headings in the first table. Also they are genotyping a lot: averaging > than 25% of cases during Nov/Dec surge, And even higher proportion in recent weeks
• • •
Missing some Tweet in this thread? You can try to
force a refresh
